Ocular Therapeutix, Inc. (OCUL) ownership: Avoro Life Sciences Fund LLC 9% · institutions 97% · index and ETF funds 5% (13F 2026-03-31). Insider activity, 90 days: Routine (1 sales, 0 open-market buys). SEC EDGAR first-party data.
| Holder | Shares | Market Value | % Outstanding | Reported |
|---|---|---|---|---|
| FMR (Fidelity) | 32653764.00 | $276.58M | 14.9% | 2026-03-31 |
| Deep Track Capital, LP | 19686282.00 | $166.74M | 9.0% | 2026-03-31 |
| BlackRock | 16132931.00 | $136.65M | 7.3% | 2026-03-31 |
| Avoro Capital Advisors LLC | 12315000.00 | $104.31M | 5.6% | 2026-03-31 |
| Summer Road LLC | 11879825.00 | $100.62M | 5.4% | 2026-03-31 |
| Vanguard | 11771613.00 | $99.71M | 5.4% | 2026-03-31 |
| Venrock Adviser, LLC | 10346926.00 | $87.64M | 4.7% | 2026-03-31 |
| Adage Capital Partners Gp, L.l.c. | 4625050.00 | $56.15M | 2.1% | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-16 | |
| Sell | null | 2026-06-10 | |
| Sell | null | 2026-06-10 | |
| Sell | null | 2026-06-10 | |
| Sell | null | 2026-06-10 | |
| Sell | null | 2026-06-10 | |
| Sell | null | 2026-06-10 | |
| Sell | null | 2026-06-10 |
Back to OCUL overview · OCUL earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.